Recent Advances in Antitumor Nanomedicine Based on Covalent Organic Frameworks

Fan Xu1,2, Ruoyu Wang3, Zhenyang Cheng1,2

  • 1Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China.

Insights

Covalent organic frameworks (COFs) offer advanced nanotechnology for cancer treatment. These novel nanomaterials show promise for improved cancer imaging and therapy, addressing limitations of current methods.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Oncology

Background:

  • Cancer poses a significant global health challenge, with conventional treatments facing limitations.
  • Nanotechnology offers innovative solutions for cancer diagnosis and therapy.
  • Covalent organic frameworks (COFs) are emerging as promising nanomaterials in this field.

Purpose of the Study:

  • To review recent advancements in the synthesis and application of COFs for cancer.
  • To highlight the unique properties of COFs compared to traditional nanomaterials.
  • To discuss the development of COF-based nanoplatforms for integrated cancer imaging and treatment.

Main Methods:

  • Review of recent literature on COF synthesis and applications in oncology.
  • Analysis of COF properties, including morphology, porosity, and biocompatibility.
  • Evaluation of tumor microenvironment-responsive release mechanisms of COFs.

Main Results:

  • COFs exhibit tunable properties, adjustable porosity, and intelligent responsive release.
  • Multifunctional COF-based nanoplatforms demonstrate potential for cancer imaging and therapy.
  • COFs show promise in overcoming limitations of conventional cancer treatments.

Conclusions:

  • COFs represent a novel class of nanomaterials with significant potential in cancer diagnosis and treatment.
  • Further research into COF-based nanoplatforms could lead to new strategies for tumor prevention and therapy.
  • Addressing current challenges will be crucial for the clinical translation of COF-based cancer therapeutics.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...